TY - JOUR
T1 - SARS-CoV-2 Gastrointestinal Shedding in Hospitalized Children
AU - Tam, Ivy
AU - McNamara, Courtney
AU - Dunbar, Julie
AU - O'Connor, Katherine
AU - Manzano, Gonzalo
AU - Cabana, Michael D.
AU - Hametz, Patricia A.
N1 - Funding Information:
FUNDING: This work was supported by the Department of Pediatrics at the Albert Einstein College of Medicine. CONFLICT OF INTEREST DISCLOSURE: The authors have indicated they have no conflicts of interest relevant to this article to disclose. Dr Tam conceptualized and designed the research project, coordinated and participated in data collection, analyses, and interpretation, drafted the initial manuscript, and reviewed and revised the manuscript; Dr McNamara participated in data collection, analyses, and interpretation and reviewed and revised the manuscript; Dr Dunbar participated in data collection, analyses, and interpretation and reviewed and revised the manuscript; Dr O’Connor participated in data collection, analyses, and interpretation and reviewed and revised the manuscript; Dr Manzano participated in data interpretation and reviewed and revised the manuscript; Drs Cabana and Hametz conceptualized and designed the research project and reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Publisher Copyright:
Copyright © 2022 by the American Academy of Pediatrics.
PY - 2022/2
Y1 - 2022/2
N2 - BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory virus that can cause gastrointestinal (GI) symptoms, with studies demonstrating detection of stool viral RNA weeks after respiratory tract clearance. It is unknown if children who test negative for SARS-CoV-2 on a nasopharyngeal (NP) swab may be shedding the virus in their stool. OBJECTIVE: To measure the prevalence of SARS-CoV-2 stool shedding in children with positive and negative SARS-CoV-2 NP polymerase chain reactions (PCR) tests, and to determine clinical factors associated with GI shedding. METHODS: In this cross-sectional study, we enrolled hospitalized patients 0 to 21 years old with a positive or a negative SARS-CoV-2 NP PCR test who had respiratory and/or GI symptoms. Participants were surveyed, and stool samples were sent for viral PCR testing. Fisher's exact test was used to evaluate bivariate associations of stool PCR test positivity with categorical variables. RESULTS: Sixty-seven patients were consented; 34 patients did not provide stool samples so 33 patients were included: 17 NP-positive and 16 NP-negative for SARS-CoV-2. Eight of the 17 NP-positive patients had a positive stool PCR test for SARS-CoV-2, while none of the 16 SARS-CoV-2 NP-negative patients had a positive result (P < .01). For the 17 SARS-CoV-2 NP-positive patients, GI symptoms were associated with a positive stool PCR test (P 5.05) for SARS-CoV-2, but this association was not found for all 33 patients (P 5.11). No associations were found with patients in an immunocompromised state or those with a comorbid condition, fever and/or chills, respiratory symptoms, headache and/or myalgias, or anosmia and/or ageusia. CONCLUSIONS: SARS-CoV-2 GI shedding is common and associated with GI symptoms in NP-positive children, with 47% having positive stool PCRs for SARS-CoV-2. GI shedding was not demonstrated in SARS-CoV-2 NP-negative children.
AB - BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory virus that can cause gastrointestinal (GI) symptoms, with studies demonstrating detection of stool viral RNA weeks after respiratory tract clearance. It is unknown if children who test negative for SARS-CoV-2 on a nasopharyngeal (NP) swab may be shedding the virus in their stool. OBJECTIVE: To measure the prevalence of SARS-CoV-2 stool shedding in children with positive and negative SARS-CoV-2 NP polymerase chain reactions (PCR) tests, and to determine clinical factors associated with GI shedding. METHODS: In this cross-sectional study, we enrolled hospitalized patients 0 to 21 years old with a positive or a negative SARS-CoV-2 NP PCR test who had respiratory and/or GI symptoms. Participants were surveyed, and stool samples were sent for viral PCR testing. Fisher's exact test was used to evaluate bivariate associations of stool PCR test positivity with categorical variables. RESULTS: Sixty-seven patients were consented; 34 patients did not provide stool samples so 33 patients were included: 17 NP-positive and 16 NP-negative for SARS-CoV-2. Eight of the 17 NP-positive patients had a positive stool PCR test for SARS-CoV-2, while none of the 16 SARS-CoV-2 NP-negative patients had a positive result (P < .01). For the 17 SARS-CoV-2 NP-positive patients, GI symptoms were associated with a positive stool PCR test (P 5.05) for SARS-CoV-2, but this association was not found for all 33 patients (P 5.11). No associations were found with patients in an immunocompromised state or those with a comorbid condition, fever and/or chills, respiratory symptoms, headache and/or myalgias, or anosmia and/or ageusia. CONCLUSIONS: SARS-CoV-2 GI shedding is common and associated with GI symptoms in NP-positive children, with 47% having positive stool PCRs for SARS-CoV-2. GI shedding was not demonstrated in SARS-CoV-2 NP-negative children.
UR - http://www.scopus.com/inward/record.url?scp=85148949145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148949145&partnerID=8YFLogxK
U2 - 10.1542/hpeds.2021-006304
DO - 10.1542/hpeds.2021-006304
M3 - Article
C2 - 35028670
AN - SCOPUS:85148949145
SN - 2154-1663
VL - 12
SP - E78-E82
JO - Hospital pediatrics
JF - Hospital pediatrics
IS - 2
ER -